US equities |
SPCX $159.31 ▲+7.79% META $697.52 ▲+0.47% NVDA $221.97 ▲+2.54% MU $913.67 ▲+1.96% TSLA $386.47 ▲+3.41% AAPL $343.99 ▲+1.32% AMD $552.72 ▲+3.36% GOOGL $334.76 ▼-1.62%
FinancialContent

Latest News about SGLT2

Recent news which mentions SGLT2

2023 HFSA CME Symposium - Improving Outcomes with SGLT2 Inhibitors in Patients with Heart Failure: From Evidence to Clinical Practice
Tags New Jersey United States #HFSA2023
From PRLog
2023 ANNA CE Symposium- Newer Therapies to Optimize Outcomes in Patients with Chronic Kidney Disease
Tags ANNA23 Ckd Nephrology
From PRLog
CME Symposium- Bridging the Gap Between Evidence and Clinical Practice: Improving Outcomes with #SGLT2Inhibitors in Patients with #HeartFailure
Tickers CME
Tags Education United States New Jersey
From PRLog